First casualty in this year's IPO bull run

IPOs
1

We have the first casualty of higher GMP but tepid listing in this year’s IPO market.

Yatharth hospitals listed at 2% premium against GMP of 25-30%. Although it is up by 10% now, it is still considered as a weak listing.

  1. Is this company specific case?

  2. Or is it related to the latest weakness in markets?

  3. Will this have an impact on the upcoming IPOs ?

What are your thoughts.